Author Correction: Therapeutic advances in COVID-19 (Nature Reviews Nephrology, (2023), 19, 1, (38-52), 10.1038/s41581-022-00642-4)

Naoka Murakami; Robert Hayden; Thomas Hills; Hanny Al-Samkari; Jonathan Casey; Lorenzo Del Sorbo; Patrick R. Lawler; Meghan E. Sise; David E. Leaf

doi:10.1038/s41581-023-00686-0

Author Correction: Therapeutic advances in COVID-19 (Nature Reviews Nephrology, (2023), 19, 1, (38-52), 10.1038/s41581-022-00642-4)

Naoka Murakami, Robert Hayden, Thomas Hills, Hanny Al-Samkari, Jonathan Casey, Lorenzo Del Sorbo, Patrick R. Lawler, Meghan E. Sise, David E. Leaf

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

In the originally published version of this article, the findings of a cited reference were incorrectly reported. The description has been corrected to read “Similarly, in non-hospitalized unvaccinated older adults with mild COVID-19 symptoms, a double-blind RCT of convalescent plasma versus placebo administered within 72 hours of symptom onset reduced the progression of COVID-19 (ref. ¹⁰⁴)” (Libster, R. et al. Early high-titer plasma therapy to prevent severe Covid-19 in older adults. N. Engl. J. Med. 384, 610–618 (2021)). The error has been corrected in the HTML and PDF versions of the article.

Original language	English
Pages (from-to)	273
Number of pages	1
Journal	Nature Reviews Nephrology
Volume	19
Issue number	4
DOIs	https://doi.org/10.1038/s41581-023-00686-0
State	Published - Apr 2023

Access to Document

10.1038/s41581-023-00686-0

Cite this

@article{d3d6cca854df410b8342426d5b1ae909,

title = "Author Correction: Therapeutic advances in COVID-19 (Nature Reviews Nephrology, (2023), 19, 1, (38-52), 10.1038/s41581-022-00642-4)",

abstract = "In the originally published version of this article, the findings of a cited reference were incorrectly reported. The description has been corrected to read “Similarly, in non-hospitalized unvaccinated older adults with mild COVID-19 symptoms, a double-blind RCT of convalescent plasma versus placebo administered within 72 hours of symptom onset reduced the progression of COVID-19 (ref. 104)” (Libster, R. et al. Early high-titer plasma therapy to prevent severe Covid-19 in older adults. N. Engl. J. Med. 384, 610–618 (2021)). The error has been corrected in the HTML and PDF versions of the article.",

author = "Naoka Murakami and Robert Hayden and Thomas Hills and Hanny Al-Samkari and Jonathan Casey and {Del Sorbo}, Lorenzo and Lawler, {Patrick R.} and Sise, {Meghan E.} and Leaf, {David E.}",

note = "Publisher Copyright: {\textcopyright} 2023, Springer Nature Limited.",

year = "2023",

month = apr,

doi = "10.1038/s41581-023-00686-0",

language = "English",

volume = "19",

pages = "273",

journal = "Nature Reviews Nephrology",

issn = "1759-5061",

number = "4",

}

TY - JOUR

T1 - Author Correction

T2 - Therapeutic advances in COVID-19 (Nature Reviews Nephrology, (2023), 19, 1, (38-52), 10.1038/s41581-022-00642-4)

AU - Murakami, Naoka

AU - Hayden, Robert

AU - Hills, Thomas

AU - Al-Samkari, Hanny

AU - Casey, Jonathan

AU - Del Sorbo, Lorenzo

AU - Lawler, Patrick R.

AU - Sise, Meghan E.

AU - Leaf, David E.

PY - 2023/4

Y1 - 2023/4

N2 - In the originally published version of this article, the findings of a cited reference were incorrectly reported. The description has been corrected to read “Similarly, in non-hospitalized unvaccinated older adults with mild COVID-19 symptoms, a double-blind RCT of convalescent plasma versus placebo administered within 72 hours of symptom onset reduced the progression of COVID-19 (ref. 104)” (Libster, R. et al. Early high-titer plasma therapy to prevent severe Covid-19 in older adults. N. Engl. J. Med. 384, 610–618 (2021)). The error has been corrected in the HTML and PDF versions of the article.

AB - In the originally published version of this article, the findings of a cited reference were incorrectly reported. The description has been corrected to read “Similarly, in non-hospitalized unvaccinated older adults with mild COVID-19 symptoms, a double-blind RCT of convalescent plasma versus placebo administered within 72 hours of symptom onset reduced the progression of COVID-19 (ref. 104)” (Libster, R. et al. Early high-titer plasma therapy to prevent severe Covid-19 in older adults. N. Engl. J. Med. 384, 610–618 (2021)). The error has been corrected in the HTML and PDF versions of the article.

UR - http://www.scopus.com/inward/record.url?scp=85147501549&partnerID=8YFLogxK

U2 - 10.1038/s41581-023-00686-0

DO - 10.1038/s41581-023-00686-0

M3 - Comment/debate

C2 - 36747084

AN - SCOPUS:85147501549

SN - 1759-5061

VL - 19

SP - 273

JO - Nature Reviews Nephrology

JF - Nature Reviews Nephrology

IS - 4

ER -

Author Correction: Therapeutic advances in COVID-19 (Nature Reviews Nephrology, (2023), 19, 1, (38-52), 10.1038/s41581-022-00642-4)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this